Sierra Oncology Operating Expenses 2011-2026 | SRRA

Annual Operating Expenses Sierra Oncology

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
94.6 M	65.2 M	67 M	55.4 M	42.6 M	48.1 M	35.8 M	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
94.6 M	35.8 M	58.4 M

Quarterly Operating Expenses Sierra Oncology

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	27.9 M	-	28.6 M	20.6 M	19.8 M	18.1 M	14.5 M	16.4 M	16.1 M	25 M	13.3 M	15.2 M	13.5 M	14.6 M	16.1 M	13 M	11.8 M	10.8 M	10.2 M	10.5 M	11.2 M	9.23 M	15.3 M	12.9 M	10.6 M	11.4 M	11 M	6.61 M	6.74 M	3.27 M	3.48 M	13.5 M	2.32 M	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
28.6 M	2.32 M	13.6 M

Operating Expenses of other stocks in the Biotechnology industry

Issuer	Operating Expenses	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	432 M	-	2.43 %	$ 254 M	Germany
Amphastar Pharmaceuticals AMPH	216 M	$ 21.65	1.12 %	$ 1.01 B	USA
I-Mab IMAB	1.49 B	-	-	$ 866 M	China
Aeglea BioTherapeutics AGLE	210 M	-	-	$ 1.01 B	USA
Midatech Pharma plc MTP	4.78 M	-	-18.52 %	$ 27.3 M	Britain
Alexion Pharmaceuticals, Inc. ALXN	2.66 B	-	-	$ 40.3 B	USA
Aptorum Group Limited APM	20.7 M	$ 0.9	-0.18 %	$ 6.62 M	China
Genfit SA GNFT	78.3 M	-	2.54 %	$ 160 B	France
ACADIA Pharmaceuticals ACAD	708 M	$ 22.3	1.55 %	$ 3.7 B	USA
EyeGate Pharmaceuticals, Inc. EYEG	8.22 M	-	-1.52 %	$ 24.7 M	USA
Advaxis ADXS	22 M	-	-9.65 %	$ 45.9 M	USA
Galectin Therapeutics GALT	20.1 M	$ 2.37	1.72 %	$ 151 M	USA
AIkido Pharma AIKI	179 M	-	1.93 %	$ 17.4 M	USA
Heron Therapeutics HRTX	281 M	-	-	$ 198 M	USA
ImmuCell Corporation ICCC	9.8 M	$ 8.25	-1.26 %	$ 74.5 M	USA
Akouos AKUS	86.8 M	-	0.23 %	$ 488 M	USA
InflaRx N.V. IFRX	52.4 M	$ 1.61	8.78 %	$ 152 M	Germany
Innate Pharma S.A. IPHA	63 M	$ 1.4	-0.71 %	$ 235 M	France
Allakos ALLK	196 M	-	-	$ 28.6 M	USA
AlloVir ALVR	46.2 M	-	4.14 %	$ 49.1 M	USA
Ampio Pharmaceuticals AMPE	9.57 M	-	-11.43 %	$ 502 K	USA
Институт стволовых клеток человека ISKJ	629 M	-	-	-	Russia
Applied Molecular Transport AMTI	127 M	-	-	$ 10.1 M	USA
Inventiva S.A. IVA	36.2 M	$ 5.13	-0.39 %	$ 138 M	France
Jaguar Health JAGX	36 M	$ 0.28	-27.77 %	$ 653 K	USA
Aeterna Zentaris AEZS	13.3 M	-	5.93 %	$ 314 M	Canada
Brainstorm Cell Therapeutics BCLI	31.7 M	-	-2.5 %	$ 5.88 M	USA
Applied Therapeutics APLT	74.5 M	-	-	$ 8.42 M	USA
Aptinyx APTX	62.6 M	-	-39.0 %	$ 4.57 M	USA
AgeX Therapeutics AGE	24.2 M	-	-10.17 %	$ 12.2 K	USA
Aravive ARAV	80 M	-	-13.39 %	$ 1.45 M	USA
KalVista Pharmaceuticals KALV	161 M	$ 19.16	-2.39 %	$ 1.03 B	Britain
Aridis Pharmaceuticals ARDS	23.4 K	-	17.91 %	$ 11.1 M	USA
BioNTech SE BNTX	512 M	-	-	$ 27.2 B	Germany
Avenue Therapeutics ATXI	4.49 M	-	-52.27 %	$ 4.45 M	USA
Applied Genetic Technologies Corporation AGTC	66.5 M	-	-	$ 26.5 M	USA
Aquestive Therapeutics AQST	85.5 M	$ 4.1	0.49 %	$ 438 M	USA
Arcutis Biotherapeutics ARQT	137 M	$ 23.42	0.69 %	$ 2.98 B	USA
Ayala Pharmaceuticals AYLA	29.8 M	-	-	$ 7.46 M	Israel
Autolus Therapeutics plc AUTL	145 M	$ 1.42	-1.39 %	$ 378 M	Britain
Aptose Biosciences APTO	24.7 M	-	-45.71 %	$ 1.2 M	Canada
Ligand Pharmaceuticals Incorporated LGND	115 M	$ 241.79	4.55 %	$ 4.42 B	USA
AstraZeneca PLC AZN	17.6 B	-	-	$ 96.9 B	Britain
Eli Lilly and Company LLY	11.8 B	-	-	$ 783 B	USA
AVROBIO AVRO	71.7 M	-	1083.1 %	$ 745 M	USA
Can-Fite BioPharma Ltd. CANF	14 M	$ 2.92	0.34 %	$ 4.81 M	Israel
Esperion Therapeutics ESPR	343 M	-	-	$ 399 M	USA
BioDelivery Sciences International BDSI	106 M	-	-4.8 %	$ 255 M	USA
BeiGene, Ltd. BGNE	390 M	-	0.49 %	$ 251 B	Cayman-islands